Margrit Carlson

723 total citations
15 papers, 537 citations indexed

About

Margrit Carlson is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Margrit Carlson has authored 15 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Margrit Carlson's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Margrit Carlson is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Margrit Carlson collaborates with scholars based in United States, Germany and Philippines. Margrit Carlson's co-authors include Prakash Sista, Fred Valentine, Jacob Lalezari, Joseph J. Eron, Roberto C. Arduino, J Michael Kilby, Robert L. Murphy, Alex Dusek, Paul A. Volberding and Calvin Cohen and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Ophthalmology and Transplantation.

In The Last Decade

Margrit Carlson

15 papers receiving 520 citations

Peers

Margrit Carlson
F. Biron France
Denise Telgt Netherlands
Paul D. Griffiths United Kingdom
Massimo Cernuschi Italy
Abeer Moanna United States
L. Joseph Wheat United States
David Bibby United Kingdom
Roberto Gulminetti Italy
Ana Paula Velez United States
Zaïna Ait-Arkoub France
F. Biron France
Margrit Carlson
Citations per year, relative to Margrit Carlson Margrit Carlson (= 1×) peers F. Biron

Countries citing papers authored by Margrit Carlson

Since Specialization
Citations

This map shows the geographic impact of Margrit Carlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margrit Carlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margrit Carlson more than expected).

Fields of papers citing papers by Margrit Carlson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margrit Carlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margrit Carlson. The network helps show where Margrit Carlson may publish in the future.

Co-authorship network of co-authors of Margrit Carlson

This figure shows the co-authorship network connecting the top 25 collaborators of Margrit Carlson. A scholar is included among the top collaborators of Margrit Carlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margrit Carlson. Margrit Carlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Gaynor, Pryce, et al.. (2022). PANDEMONIUM FROM AMMONIA: DEVASTATING HYPERAMMONEMIA SECONDARY TO UREAPLASMA INFECTION IN CONGENITAL COMBINED HEART LIVER TRANSPLANT. Journal of the American College of Cardiology. 79(9). 2615–2615. 1 indexed citations
3.
Chang, Sandy Y., Travis K. Price, Joanna Schaenman, et al.. (2022). Mycoplasma hominis infections in solid organ transplant recipients: Clinical characteristics, treatment outcomes, and comparison of phenotypic and genotypic susceptibility profiles. Transplant Infectious Disease. 24(3). e13822–e13822. 4 indexed citations
4.
Lum, Erik L., Suphamai Bunnapradist, Ashrit Multani, et al.. (2020). Spectrum of Coronavirus Disease 2019 Outcomes in Kidney Transplant Recipients: A Single-Center Experience. Transplantation Proceedings. 52(9). 2654–2658. 13 indexed citations
5.
Hsu, Jeffrey J., Reza Ardehali, A. Baas, et al.. (2020). Heart transplantation in the early phase of the COVID‐19 pandemic: A single‐center case series. Clinical Transplantation. 34(9). e14042–e14042. 4 indexed citations
6.
Huang, Glen, Matthew R Davis, Margrit Carlson, et al.. (2020). 1109. Valgancyclovir Dosing for Cytomegalovirus Prophylaxis in Heart Transplant Recipients. Open Forum Infectious Diseases. 7(Supplement_1). S584–S585. 2 indexed citations
7.
Murkey, Jamie A., Kara W Chew, Margrit Carlson, et al.. (2017). Hepatitis E Virus–Associated Meningoencephalitis in a Lung Transplant Recipient Diagnosed by Clinical Metagenomic Sequencing. Open Forum Infectious Diseases. 4(3). ofx121–ofx121. 52 indexed citations
8.
Sung, Eric, et al.. (2014). Dental treatment in the cardiothoracic intensive care unit for patients with ventricular assist devices awaiting heart transplant: a case series. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 118(2). 194–201. 7 indexed citations
9.
Mehta, Seema, T. Khuu, David J. Ross, et al.. (2013). Extended Spectrum β-Lactamase–Producing Enterobacteriaceae Infection in Heart and Lung Transplant Recipients and in Mechanical Circulatory Support Recipients. Transplantation. 97(5). 590–594. 13 indexed citations
10.
Singer, Elyse J., Miguel Valdes‐Sueiras, Deborah Commins, William H. Yong, & Margrit Carlson. (2013). HIV stroke risk: evidence and implications. Therapeutic Advances in Chronic Disease. 4(2). 61–70. 39 indexed citations
11.
Holland, Gary N., Jean D. Vaudaux, Fei Yu, et al.. (2008). Characteristics of Untreated AIDS-related Cytomegalovirus Retinitis. II. Findings in the Era of Highly Active Antiretroviral Therapy (1997 to 2000). American Journal of Ophthalmology. 145(1). 12–22.e10. 67 indexed citations
12.
Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2003). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 19(1). 83–83. 6 indexed citations
13.
Lalezari, Jacob, Joseph J. Eron, Margrit Carlson, et al.. (2003). A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS. 17(5). 691–698. 113 indexed citations
14.
15.
Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2002). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 18(10). 685–693. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Biron Breakdown of academic impact, for papers by Denise Telgt Breakdown of academic impact, for papers by Paul D. Griffiths Breakdown of academic impact, for papers by Massimo Cernuschi Breakdown of academic impact, for papers by Abeer Moanna Breakdown of academic impact, for papers by L. Joseph Wheat Breakdown of academic impact, for papers by David Bibby Breakdown of academic impact, for papers by Roberto Gulminetti Breakdown of academic impact, for papers by Ana Paula Velez Breakdown of academic impact, for papers by Zaïna Ait-Arkoub
Rankless by CCL
2026